Familial Nasopharyngeal Carcinoma 6

Early Stage Nasopharyngeal Cancer: A Highly Curative Disease with Radiation Therapy 147Marks JE, Bedwinek JM, et al (1982) Dose-response analysisfor nasopharyngeal carcinoma: an historical perspective.Cancer 50(6):1042–1050Mendenhall WM, Morris CG, et al (2006) Definitive radiotherapyfor nasopharyngeal carcinoma. Am J Clin Oncol29(6):622–627Munter MW, Debus J, et al (2002) Inverse treatment planning andstereotactic intensity-modulated radiation therapy (IMRT)of the tumor and lymph node levels for nasopharyngeal carcinomas.Description of treatment technique, plan comparison,and case study. Strahlenther Onkol 178(9):517–523Neel HB 3 rd , Taylor WF (1989) New staging system for nasopharyngealcarcinoma. Long-term outcome. Arch OtolaryngolHead Neck Surg 115(11):1293–1303Ozyar E, Yildiz F, et al (1999) Comparison of AJCC 1988 and1997 classifications for nasopharyngeal carcinoma.American joint committee on cancer. Int J Radiat OncolBiol Phys 44(5):1079–1087Roh KW, Jang JS, et al (2008) Fractionated stereotactic radiotherapyas reirradiation for locally recurrent head andneck cancer. Int J Radiat Oncol Biol PhysSanchiz F, Milla A, et al (1990) Single fraction per day versustwo fractions per day versus radiochemotherapy in thetreatment of head and neck cancer. Int J Radiat Oncol BiolPhys 19(6):1347–1350Sanguineti G, Geara FB, et al (1997) Carcinoma of thenasopharynx treated by radiotherapy alone: determinantsof local and regional control. Int J Radiat Oncol Biol Phys37(5):985–996Song CH, Wu HG, et al (2008) Treatment outcomes forradiotherapy alone are comparable with neoadjuvantchemotherapy followed by radiotherapy in early-stagenasopharyngeal carcinoma. Laryngoscope 118(4):663–670Sultanem K, Shu HK, et al (2000) Three-dimensional intensitymodulatedradiotherapy in the treatment of nasopharyngealcarcinoma: the University of California-San Franciscoexperience. Int J Radiat Oncol Biol Phys 48(3):711–722Teo P, Lee WY, et al (1996) The prognostic significance ofparapharyngeal tumour involvement in nasopharyngealcarcinoma. Radiother Oncol 39(3):209–221Teo PM, Leung SF, et al (1991) A comparison of Ho’s,International Union Against Cancer, and American JointCommittee stage classifications for nasopharyngeal carcinoma.Cancer 67(2):434–439Teo PM, Leung SF, et al (2000) Final report of a randomizedtrial on altered-fractionated radiotherapy in nasopharyngealcarcinoma prematurely terminated by significant increasein neurologic complications. Int J Radiat Oncol Biol Phys48(5):1311–1322Tham IW, Hee SW, et al. (2009) Treatment of NasopharyngealCarcinoma Using Intensity-Modulated Radiotherapy-TheNational Cancer Centre Singapore Experience. Int J RadiatOncol Biol Phys 2009 Apr 20. [Epub ahead of print]Verhey LJ (1999) Comparison of three-dimensional conformalradiation therapy and intensity-modulated radiation therapysystems. Semin Radiat Oncol 9(1):78–98Vikram B, Mishra UB, et al (1985) Patterns of failure in carcinomaof the nasopharynx: I. Failure at the primary site. IntJ Radiat Oncol Biol Phys 11(8):1455–1459Wang CC (1991) Improved local control of nasopharyngealcarcinoma after intracavitary brachytherapy boost. AmJ Clin Oncol 14(1):5–8Wang CC, Busse J, et al (1975) A simple afterloading applicatorfor intracavitary irradiation of carcinoma of the nasopharynx.Radiology 115(3):737–738Wee J, Tan EH, et al (2004) Phase III randomized trial of radiotherapyversus concurrent chemotherapy followed byadjuvant chemotherapy in patients with AJCC/UICC (1997)stage 3 and 4 nasopharyngeal cancer of the endemic variety.Proceedings of the American Society of ClinicalOncology. J Clin Oncol 23:487Wilson CP (1950) The approach to the nasopharynx. Proc ResSoc Med 44:353–358Xiao GL, Gao L, et al (2002) Prognostic influence of parapharyngealspace involvement in nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys 52(4):957–963Xiao J, Xu G, et al (2001) Fractionated stereotactic radiosurgeryfor 50 patients with recurrent or residual nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 51(1):164–170Xiao WW, Han F, et al (2009) Treatment outcomes after radiotherapyalone for patients with early-stage nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 74:1070–1076Yeh SA, Tang Y, et al (2005) Treatment outcomes and late complicationsof 849 patients with nasopharyngeal carcinomatreated with radiotherapy alone. Int J Radiat Oncol BiolPhys 62(3):672–679Yip TT, Ngan RK, et al (1994) A possible prognostic role ofimmunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA inpatients with nasopharyngeal carcinoma. Cancer 74(9):2414–2424